Schedule 13G ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2018-01-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-18-000055
- Form type
- SC 13G
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- Jan 22, 2018
- Reporting period
- Jan 11, 2018
- Description
- Schedule 13G beneficial ownership